Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Orchestra BioMed Holdings (OBIO) Depreciation & Amortization - Total (2024 - 2025)

Historic Depreciation & Amortization - Total for Orchestra BioMed Holdings (OBIO) over the last 2 years, with Q3 2025 value amounting to $81000.0.

  • Orchestra BioMed Holdings' Depreciation & Amortization - Total rose 657.89% to $81000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $329000.0, marking a year-over-year increase of 4687.5%. This contributed to the annual value of $308000.0 for FY2024, which is 731.71% up from last year.
  • As of Q3 2025, Orchestra BioMed Holdings' Depreciation & Amortization - Total stood at $81000.0, which was up 657.89% from $81000.0 recorded in Q2 2025.
  • Orchestra BioMed Holdings' 5-year Depreciation & Amortization - Total high stood at $84000.0 for Q4 2024, and its period low was $74000.0 during Q1 2024.